Pro Medicus Ltd (PME.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -363 | -342 | -219 | -80 | -222 |
| Purchase Sale Intangibles | -7,508 | -7,207 | -6,164 | N/A | N/A |
| Other Investing Activity | 172 | 244 | 56 | -6,048 | -5,551 |
| Investing Cash Flow | $-7,699 | $-7,305 | $-6,327 | $-6,128 | $-5,773 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 25 | 635 | 975 |
| Common Stock Repurchased | -842 | N/A | N/A | -73 | N/A |
| Dividend Paid | -10,916 | -9,843 | -5,150 | -3,075 | -2,532 |
| Other Financing Activity | -557 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-12,315 | $-9,843 | $-5,125 | $-2,513 | $-1,557 |
| Exchange Rate Effect | -308 | -433 | 42 | -520 | 248 |
| Beginning Cash Position | 32,315 | 25,238 | 22,775 | 17,107 | 12,935 |
| End Cash Position | 43,413 | 32,315 | 25,238 | 22,775 | 17,107 |
| Net Cash Flow | $11,406 | $7,510 | $2,421 | $6,188 | $3,924 |
| Free Cash Flow | |||||
| Capital Expenditure | -7,871 | -7,549 | -12,547 | -6,150 | -5,829 |
| Free Cash Flow | -7,871 | -7,549 | -12,547 | -6,150 | -5,829 |